Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, August 23, 2014
Technology Networks
 
Register | Sign in
Home Page>News

  News Archive

NIH Launches 3 Integrated Precision Medicine Trials
Wednesday, August 20, 2014
Findings to answer questions about addition of targeted therapies in earlier stage disease and help understand the prevalence and natural history of these genomic changes in earlier stage lung cancer.

WuXi Facility Passes FDA API Manufacture Inspection
Wednesday, August 20, 2014
Company's wholly owned subsidiary Shanghai SynTheAll Pharmaceutical (STA) passed an FDA inspection in July for the manufacture of the active pharmaceutical ingredient (API) for a branded commercial drug.

ADME of Antibody-Maytansinoid Conjugates
Wednesday, August 20, 2014
Continued understanding of the ADME properties of ADCs entering clinical evaluations should provide additional insight into attributes that may be necessary for clinical success.

Allied Minds, B-MS Form Biopharma Enterprise
Thursday, August 07, 2014
Unique collaboration focused on transforming early-stage academic innovation to therapeutic candidates for clinical study.

Reprocell Acquires Reinnervate and BioServe
Tuesday, August 05, 2014
The company group now offers products and services that spans 2D and 3D cell culture, stem cell culture media, iPSC-derived cells and human tissue samples.

Molecular Profiles, XenoGesis Collaborate
Monday, August 04, 2014
Partnership will support pharmaceutical and biotech drug developers during the pre-clinical and formulation development stage.

SGS Life Science to Expand Shanghai Facility
Monday, August 04, 2014
Company will expand its Shanghai cGMP chemistry and microbiology laboratories to 2000m2 by Q2 2015.

AstraZeneca Buys Rights to Almirall Respiratory Franchise
Monday, August 04, 2014
AstraZeneca agrees an initial consideration of $875 million on completion, which may rise to $1.22 billion in development, launch, and sales-related milestones.

Epigenetic Regulation of ADME-Related Genes
Monday, August 04, 2014
The promise of epigenetic research is its potential to identify additional sources of inter individual variability in drug disposition and response.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 2332
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv